56%, respectively mainly due to the increase of income coupled with the decrease of financing cost. In addition, during 1Q17, its subsidiary (Rajthanee Rojana Hospital Co., Ltd.) has recognized income
the paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that
paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that, prior
paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that, prior
period decrease significantly 32 percent from the impact of the financial cost increasing from the provision of source of fund for the Company’s investment. Financial Position: Consolidated Financial
-term loan. Whereas the Company’s shareholder’s equity stood at 943.0 million Baht, slightly decrease from the end of 2018. The Company’s debt to equity ratio was 1.61 times while the interest bearing
baht, an decrease by 186.1 million baht from the end of 2018 which as a result of dividend payout from retain earning of the Company. The Company’s Debt to Equity Ratio is 1.94 times and the Interest
was mainly from the decrease in long-term loans from financial institutions due within one year 12.3 million baht. While employee benefit obligations increased 2.1 million baht. (3) Shareholders’ Equity
the decrease in production capacity and the production loss in the United States of America. The Company has a gross margin for the first six month in total of 706.0 million Baht or equal to 27.3
to an increase in cash of Bt95 million, a small decrease in the value of property, plant and equipment-net (consisting of the acquisition of an additional investment in a new factory of Bt320 million